Methods: This is a multi-site, individually randomised, superiority trial with an embedded process evaluation and an economic analysis of cost effectiveness. The trial will compare an experimental strategy of offering a 12-week GYY programme against a control strategy of no offer in community-dwelling adults aged 65 or over who have multimorbidity, defined as having two or more chronic conditions from a predefined list. The primary outcome is health-related quality of life measured using the EQ-5D-5L; the primary endpoint being the overall difference over 12 months. Both groups will continue to be able to access their usual care from primary, secondary, community and social services. Participants, care providers and yoga teachers will not be blinded to the allocated intervention. Outcome measures are primarily self-reported. Analysis will follow intention-to-treat principles.
Discussion: This pragmatic randomised controlled trial will demonstrate if the GYY programme is an effective, cost-effective, and viable addition to the management of older adults with multimorbidity.
|Publication status||Accepted/In press - 23 Mar 2021|